We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Immunology
Oncology Session - April 7, 2021, Aaron Rose, Ph.D.

Oncology Session - April 7, 2021, Aaron Rose, Ph.D.

Published Date April 8, 2021

Talk Title: Are Young Mice the Right Tool for Evaluation of Immunotherapeutics? Aged C57Bl/6J Mice for Syngeneic Studies

Previous Video

MiceTech Talk Episode 34: Let’s Talk Scientific Sessions – Oncology (Apr. 13, 2021)

April 13, 2021 - In today’s episode, we will discuss the latest developments in oncology research which were shared during the April 7, 2021 JAX Scientific Session.
Next Article

CRS: FAQs

The JAX CRS assay has a highly flexible design applicable to a wide variety of human specific immune modulatory therapies. The assay can test both immunostimulatory and immunosuppressive therapies.

Other content in this Stream

almost 3 years ago
2022 SfN Poster: TGN1412-Induced Cytokine Release Syndrome and Pathological Evaluation in a Humanized PBMC Mouse Model

Read Flipbook
over 3 years ago
Important Considerations for Generating Genetic Humanized Mouse Models

The term humanization is used, to much confusion, to mean several different things in mouse research. While broad in scope and technique, all humanized mouse models share a common goal – to better lev

Learn More
Genetically Diverse Mouse Models for Every Stage of the Research Pipeline

Mouse research is often performed in genetically-defined inbred mouse strains, where each mouse within a strain is virtually identical to one another.

Learn More
over 3 years ago
MiceTech Talk Episode 35: Let's Talk SARS-CoV-2 Testing in Mouse Models (Apr. 27, 2021)

April 27, 2021 - In this episode, we discuss the latest research on the topic and provide up-to-date information on current best practices.

Watch Video
almost 4 years ago
MiceTech Talk Episode 34: Let’s Talk Scientific Sessions – Oncology (Apr. 13, 2021)

April 13, 2021 - In today’s episode, we will discuss the latest developments in oncology research which were shared during the April 7, 2021 JAX Scientific Session.

Watch Video
over 3 years ago
CRS: FAQs

The JAX CRS assay has a highly flexible design applicable to a wide variety of human specific immune modulatory therapies. The assay can test both immunostimulatory and immunosuppressive therapies.

Learn More
almost 4 years ago
Novel antibody tests reveal complexity of immune response to covid-19

Learn More
almost 4 years ago
CAR T therapy testing—how it started and how it’s going

At The Jackson Laboratory (JAX), we are working with our customers to test CAR T efficacy in solid and disseminated tumors and investigate new models of efficacy and safety testing of this nascent the

Learn More
almost 4 years ago
Exclusively from JAX: The COVID-19 Model Portfolio

We invite you to explore our comprehensive portfolio of COVID-19 models.

Learn More
almost 4 years ago
Using Humanized In Vivo Models for Preclinical Antibody Development: A Case Study

Read Flipbook
almost 4 years ago
Targeting Natural Killer Cell Activity with Humanized NSG IL-15 Mouse Model

The NEW cord blood CD34+ HSC humanized NSG-IL15 mouse enables efficacy research for compounds targeting human natural killer (NK) cell activity including antibody-dependent cellular cytotoxicity.

Read Flipbook
about 4 years ago
MiceTech Talk Episode 24: Let's Talk Caring for Immunodeficient Mice (Nov. 17, 2020)

November 17, 2020 - In this episode, we share recommendations from our JAX clinical veterinary team on caring for immunodeficient mice.

Watch Video
over 4 years ago
An Introduction to Human FcRn Mice - Greg Christianson

Watch Video
over 4 years ago
JAX Guide: Assessing Antibody Pharmacokinetics Using the JAX FcRn Platform

Read Flipbook
over 4 years ago
Case Study: PK/PD, Safety, and Efficacy Platforms

Read Flipbook
over 4 years ago
Poster: PK/PD, Safety, and Efficacy Platforms

Learn More
over 4 years ago
Preclinical Evaluation of Efficacy and Cytokine Release of Bispecific T Cell Engagers in Hu-NSG Mice

Dr. Li-Chin Yao of The Jackson Laboratory outlines her latest work on humanized NSG mice to test efficacy and cytokine release of bispecific T cell engagers

Watch Video
over 4 years ago
An In Vivo Model to Evaluate Donor-Dependent Cytokine Release

Watch Video
over 4 years ago
Effects of Aging on Immunosenescence and Checkpoint Inhibitor Efficacy in a C57BL/6J Syngeneic Model

Dr. Jiwon Yang discusses establishing a mouse model that exhibits immunosenescence and studying how immunosenescence affects checkpoint inhibitor efficacy in a C57BL/6J syngeneic model.

Watch Video
over 4 years ago
Part 2 of a 3-part Humanized Mouse Series: What to Consider When Humanizing an Immunodeficient Mouse

Join Rick Huntress and Natalie Hurlen, Ph.D. on Wednesday, August 12 as they discuss humanizing immunodeficient mice. Learn more here: https://resources.jax.org/jax-blog/working-with-humanized-nsg-mic

Watch Video

Recommended for you

Return to Home

© The Jackson Laboratory